2BBBullish & Bearish
Neumora Therapeutics, Inc. (NMRA) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 25 out of 100.
Neumora Therapeutics, Inc.’s current 2BB score is 25 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 8 | Very Weak |
| Quality | 80 | Very Strong |
| Risk | 0 | Very Low |
| Headquarters | Watertown, Massachusetts, United States |
| Founded | 2019 |
| Employees | 92 |
| 52-week range | $0.77 – $3.65 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-08-12 | — | -0.2448 | — | $0.00 |
| 2026-05-12 | — | -0.3162 | — | $0.00 |
| 2026-03-30 | — | -0.3321 | — | $0.00 |